DPI-221
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 4-((αS)-α-((2S,5R)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 9891642 |
| Chemical data | |
| Formula | C21H38FN3O |
| Mol. mass | 487.65 g/mol |
| SMILES | eMolecules & PubChem |
 (what is this?) (verify) |
DPI-221 is a drug that is used in scientific research. It is a highly selective agonist for the δ-opioid receptor, which produces fewer convulsions than most drugs from this family.[1]
[edit] References
- ^ Holt, JD; Watson, MJ; Chang, JP; O'Neill, SJ; Wei, K; Pendergast, W; Gengo, PJ; Chang, KJ (2005). "DPI-221 4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats". The Journal of pharmacology and experimental therapeutics 315 (2): 601–8. doi:10.1124/jpet.105.090498. PMID 16020629.
 |
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
